| UniProt ID | AP4AT_HUMAN | |
|---|---|---|
| UniProt AC | Q96N21 | |
| Protein Name | AP-4 complex accessory subunit Tepsin {ECO:0000305} | |
| Gene Name | TEPSIN {ECO:0000303|PubMed:22472443, ECO:0000312|HGNC:HGNC:26458} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 525 | |
| Subcellular Localization |
Golgi apparatus, trans-Golgi network membrane Peripheral membrane protein . Cytoplasmic vesicle . Cytoplasm, cytosol . Extensively colocalizes with AP-4 which mediates the recruitment of TEPSIN to the trans-Golgi network. |
|
| Protein Description | Associates with the adapter-like complex 4 (AP-4) and may therefore play a role in vesicular trafficking of proteins at the trans-Golgi network.. | |
| Protein Sequence | MAAAPPLRDRLSFLHRLPILLKGTSDDDVPCPGYLFEEIAKISHESPGSSQCLLEYLLSRLHSSSGHGKLKVLKILLYLCSHGSSFFLLILKRNSAFIQEAAAFAGPPDPLHGNSLYQKVRAAAQDLGSTLFSDTVLPLAPSQPLGTPPATGMGSQARPHSTLQGFGYSKEHGRTAVRHQPGQAGGGWDELDSGPSSQNSSQNSDLSRVSDSGSHSGSDSHSGASREPGDLAERVEVVALSDCQQELSLVRTVTRGPRAFLSREEAQHFIKACGLLNCEAVLQLLTCHLRGTSECTQLRALCAIASLGSSDLLPQEHILLRTRPWLQELSMGSPGPVTNKATKILRHFEASCGQLSPARGTSAEPGPTAALPGPSDLLTDAVPLPGSQVFLQPLSSTPVSSRSPAPSSGMPSSPVPTPPPDASPIPAPGDPSEAEARLAESRRWRPERIPGGTDSPKRGPSSCAWSRDSLFAGMELVACPRLVGAGAAAGESCPDAPRAPQTSSQRTAAKEPPGSEPSAFAFLNA | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 12 | Phosphorylation | PPLRDRLSFLHRLPI CCHHHHHHHHHHHCC | 27.02 | 20873877 | |
| 22 | Ubiquitination | HRLPILLKGTSDDDV HHHCCCCCCCCCCCC | 57.61 | 29967540 | |
| 23 (in isoform 2) | Phosphorylation | - | 30.35 | 28450419 | |
| 25 (in isoform 2) | Phosphorylation | - | 47.94 | 28450419 | |
| 32 (in isoform 2) | Phosphorylation | - | 28.52 | 20068231 | |
| 33 (in isoform 2) | Phosphorylation | - | 38.19 | 20068231 | |
| 43 (in isoform 2) | Phosphorylation | - | 22.09 | 22210691 | |
| 51 (in isoform 2) | Phosphorylation | - | 24.47 | 25159151 | |
| 53 (in isoform 2) | Phosphorylation | - | 2.93 | 28450419 | |
| 54 (in isoform 2) | Phosphorylation | - | 5.52 | 28450419 | |
| 170 | Ubiquitination | LQGFGYSKEHGRTAV CCCCCCCCCCCCCEE | 45.29 | - | |
| 201 | Phosphorylation | GPSSQNSSQNSDLSR CCCCCCCCCCCCCCC | 40.71 | - | |
| 248 | Phosphorylation | SDCQQELSLVRTVTR HHHHHHHHHHHHHCC | 24.86 | 24719451 | |
| 252 | Phosphorylation | QELSLVRTVTRGPRA HHHHHHHHHCCCCCC | 20.81 | 27174698 | |
| 254 | Phosphorylation | LSLVRTVTRGPRAFL HHHHHHHCCCCCCCC | 29.33 | 27174698 | |
| 262 | Phosphorylation | RGPRAFLSREEAQHF CCCCCCCCHHHHHHH | 31.06 | - | |
| 322 | Phosphorylation | QEHILLRTRPWLQEL HHHHHHHCCHHHHHH | 40.84 | 23403867 | |
| 330 | Phosphorylation | RPWLQELSMGSPGPV CHHHHHHHCCCCCCC | 21.98 | 23927012 | |
| 333 | Phosphorylation | LQELSMGSPGPVTNK HHHHHCCCCCCCCHH | 20.31 | 23401153 | |
| 338 | Phosphorylation | MGSPGPVTNKATKIL CCCCCCCCHHHHHHH | 33.85 | 23927012 | |
| 340 | Acetylation | SPGPVTNKATKILRH CCCCCCHHHHHHHHH | 48.33 | 25953088 | |
| 340 | Malonylation | SPGPVTNKATKILRH CCCCCCHHHHHHHHH | 48.33 | 26320211 | |
| 351 | Phosphorylation | ILRHFEASCGQLSPA HHHHHHHHCCCCCCC | 16.16 | 23403867 | |
| 356 | Phosphorylation | EASCGQLSPARGTSA HHHCCCCCCCCCCCC | 14.50 | 22167270 | |
| 395 | Phosphorylation | QVFLQPLSSTPVSSR EEEEEECCCCCCCCC | 38.56 | 28348404 | |
| 396 | Phosphorylation | VFLQPLSSTPVSSRS EEEEECCCCCCCCCC | 44.40 | 28348404 | |
| 397 | Phosphorylation | FLQPLSSTPVSSRSP EEEECCCCCCCCCCC | 25.08 | 28348404 | |
| 400 | Phosphorylation | PLSSTPVSSRSPAPS ECCCCCCCCCCCCCC | 22.65 | 22210691 | |
| 401 | Phosphorylation | LSSTPVSSRSPAPSS CCCCCCCCCCCCCCC | 36.69 | 32645325 | |
| 403 | Phosphorylation | STPVSSRSPAPSSGM CCCCCCCCCCCCCCC | 27.62 | 29978859 | |
| 407 | Phosphorylation | SSRSPAPSSGMPSSP CCCCCCCCCCCCCCC | 41.45 | 29978859 | |
| 408 | Phosphorylation | SRSPAPSSGMPSSPV CCCCCCCCCCCCCCC | 37.74 | 29978859 | |
| 412 | Phosphorylation | APSSGMPSSPVPTPP CCCCCCCCCCCCCCC | 38.08 | 28348404 | |
| 413 | Phosphorylation | PSSGMPSSPVPTPPP CCCCCCCCCCCCCCC | 24.85 | 28985074 | |
| 417 | Phosphorylation | MPSSPVPTPPPDASP CCCCCCCCCCCCCCC | 48.97 | 24719451 | |
| 423 | Phosphorylation | PTPPPDASPIPAPGD CCCCCCCCCCCCCCC | 30.64 | 29978859 | |
| 453 | Phosphorylation | PERIPGGTDSPKRGP CCCCCCCCCCCCCCC | 38.94 | 29255136 | |
| 455 | Phosphorylation | RIPGGTDSPKRGPSS CCCCCCCCCCCCCCC | 31.96 | 29255136 | |
| 457 | Ubiquitination | PGGTDSPKRGPSSCA CCCCCCCCCCCCCCC | 74.14 | 29967540 | |
| 492 | Phosphorylation | AGAAAGESCPDAPRA CCHHCCCCCCCCCCC | 29.99 | 28555341 | |
| 503 | Phosphorylation | APRAPQTSSQRTAAK CCCCCCCCCCCCCCC | 21.16 | 28555341 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of AP4AT_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of AP4AT_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AP4AT_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| A4_HUMAN | APP | physical | 21832049 | |
| HNRPC_HUMAN | HNRNPC | physical | 26496610 | |
| GRP78_HUMAN | HSPA5 | physical | 26496610 | |
| IMDH2_HUMAN | IMPDH2 | physical | 26496610 | |
| TNPO1_HUMAN | TNPO1 | physical | 26496610 | |
| LAMA2_HUMAN | LAMA2 | physical | 26496610 | |
| RL10_HUMAN | RPL10 | physical | 26496610 | |
| BACD2_HUMAN | TNFAIP1 | physical | 26496610 | |
| RBM10_HUMAN | RBM10 | physical | 26496610 | |
| BAP1_HUMAN | BAP1 | physical | 26496610 | |
| M2OM_HUMAN | SLC25A11 | physical | 26496610 | |
| AP4M1_HUMAN | AP4M1 | physical | 26496610 | |
| SCAM3_HUMAN | SCAMP3 | physical | 26496610 | |
| SF3A1_HUMAN | SF3A1 | physical | 26496610 | |
| YMEL1_HUMAN | YME1L1 | physical | 26496610 | |
| SF3B2_HUMAN | SF3B2 | physical | 26496610 | |
| AP4S1_HUMAN | AP4S1 | physical | 26496610 | |
| AP4E1_HUMAN | AP4E1 | physical | 26496610 | |
| SF3B1_HUMAN | SF3B1 | physical | 26496610 | |
| UNC50_HUMAN | UNC50 | physical | 26496610 | |
| NARF_HUMAN | NARF | physical | 26496610 | |
| RT18B_HUMAN | MRPS18B | physical | 26496610 | |
| MED31_HUMAN | MED31 | physical | 26496610 | |
| STK26_HUMAN | STK26 | physical | 26496610 | |
| KI16B_HUMAN | KIF16B | physical | 26496610 | |
| DERL1_HUMAN | DERL1 | physical | 26496610 | |
| ISCA1_HUMAN | ISCA1 | physical | 26496610 | |
| ASCC2_HUMAN | ASCC2 | physical | 26496610 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-333; SER-356 ANDSER-455, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-51 (ISOFORM 2),AND MASS SPECTROMETRY. | |
| "Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-356, AND MASSSPECTROMETRY. | |